Literature DB >> 23471105

Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancer.

Y H Yun1, E-J Shon, A-J Yang, S H Kim, Y A Kim, Y J Chang, J Lee, M S Kim, H-S Lee, J I Zo, J Kim, Y S Choi, Y M Shim.   

Abstract

BACKGROUND: To evaluate the long-term needs of lung cancer survivors and to explore factors associated with unmet need. PATIENTS AND METHODS: We recruited lung patients treated with curative surgery from 2001 through 2006 at two centers in Korea. Needs in the domains of information, supportive care, education and counseling, and socioeconomic support were measured. We selected the four most frequently reported items of unmet need among 19 items in four domains.
RESULTS: The most frequently reported unmet needs were Complementary and alternative medicine (CAM) and folk remedies (59.8%) in the Information domain, Counseling and treatment of depression and anxiety (63.5%) in the Supportive care domain, diet, exercise and weight control (55.1%) in the Education and counseling domain and Financial support (90.4%) in the socioeconomic support domain. Unmet needs for psychological treatment was significantly greater in participants who were employed (adjusted odds ratio [aOR], 2.25; 95% confidential interval [CI], 1.12 to 4.53). Unmet needs for diet, exercise and weight control were significantly greater in participants who had not received chemotherapy (aOR, 1.76; 95% CI, 1.09 to 2.85). Unmet need for financial support was greater in participants who were married (aOR, 4.14, 95%CI, 1.12 to 15.22) and those who had not received chemotherapy (aOR, 5.91, 95%CI, 1.91 to 18.31).
CONCLUSION: There were substantial unmet needs for information regarding psychological support, education for diet and exercise, and financial support among lung cancer survivors.

Entities:  

Keywords:  lung cancer; survivors; unmet need

Mesh:

Year:  2013        PMID: 23471105     DOI: 10.1093/annonc/mdt032

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  6 in total

1.  Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways.

Authors:  Jie Li; Fang Liu; Shulong Jiang; Jie Liu; Xiuhong Chen; Shangnuan Zhang; Haibo Zhao
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

2.  Trans-sectoral care in patients with colorectal cancer: Protocol of the randomized controlled multi-center trial Supportive Cancer Care Networkers (SCAN).

Authors:  Alexander Bauer; Dirk Vordermark; Thomas Seufferlein; Hans-Joachim Schmoll; Henning Dralle; Wilfried Mau; Susanne Unverzagt; Stephanie Boese; Eva-Maria Fach; Margarete Landenberger
Journal:  BMC Cancer       Date:  2015-12-22       Impact factor: 4.430

3.  The major effects of health-related quality of life on 5-year survival prediction among lung cancer survivors: applications of machine learning.

Authors:  Jin-Ah Sim; Young Ae Kim; Ju Han Kim; Jong Mog Lee; Moon Soo Kim; Young Mog Shim; Jae Ill Zo; Young Ho Yun
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

4.  Evaluating the Effects of a Mobile Health App on Reducing Patient Care Needs and Improving Quality of Life After Oral Cancer Surgery: Quasiexperimental Study.

Authors:  Tze-Fang Wang; Rou-Chen Huang; Su-Chen Yang; Chyuan Chou; Lee-Chen Chen
Journal:  JMIR Mhealth Uhealth       Date:  2020-07-27       Impact factor: 4.773

5.  A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer.

Authors:  Ellen Conte; Mark Legacy; Athanasios Psihogios; Anne Pitman; Andrea Redway; Jill Hamer-Wilson; Dugald Seely
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

6.  A rehabilitation program for lung cancer patients during postthoracotomy chemotherapy.

Authors:  Amy J Hoffman; Ruth Ann Brintnall; Alexander von Eye; Lee W Jones; Gordon Alderink; Lawrence H Patzelt; Jean K Brown
Journal:  Onco Targets Ther       Date:  2014-03-10       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.